An interventional study of Cention-N and Resin Composite in Dental Caries, sponsored by Minia University. Recruiting at 1 site in Egypt. Open to participants aged 8 Years to 10 Years. Per ClinicalTrials.gov, last updated 2026-07-15.
Sponsored by Minia University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 207 studies in Dental Caries with a site in Egypt — 47 open to participants now, 67 under way, 1 of them phase 3. Dental Caries · Egypt.
Among the 207 studies in Dental Caries with a site in Egypt, this one is the 24th largest by planned enrollment of the 180 interventional ones that give a count, is one of 13 that started in 2026, is one of 154 with no phase, reaches primary completion later than 56 of the 66 other live ones, and was the 193rd registered.
1,176 studies on the registry are indexed under Dental Caries; 209 are open to participants now.
Browse Dental Caries studies →47 of the 207 studies in Dental Caries with a site in Egypt are open now. Recruiting first, the newest first:
October University for Modern Sciences and Arts · Sites in Egypt
Ages 18–65 · Healthy volunteers
Mansoura University · Sites in Egypt
Ages 15–20
Assiut University · Sites in Egypt
Ages 3–8
Mansoura University · Sites in Egypt
Ages 6–9
Mansoura University · Sites in Egypt
Ages 14–26
A study can be open while its sites in Egypt have not opened yet or have stopped. Only those recruiting at a site in Egypt →
Of the 86 Dental Caries studies recruiting now, 18 (21%) set no upper age limit and 66 (77%) stop at 75 or younger; 60 take children under 18; 53 take healthy volunteers.
This study: 8 Years to 10 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
207 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 4 · Phase 2 8 · Phase 3 8 · Phase 4 9
First in 2011; this study’s year is marked. 13 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 100 is above the median of 60 across 967 interventional studies indexed under Dental Caries.
Median enrollment 43 across the 180 interventional studies, 204 across the 27 observational. Of the 105 that completed or were terminated, 2 (2%) have results posted.
This tab as a report to print or save as PDF → With an account.
2 of 207 have an industry lead sponsor. The 10 most frequent:
Minia University is the lead sponsor of 374 studies on the registry; 121 are open to participants now.
Of its 6 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Minia University has 5 studies filed under Dental Caries — fewer than ten, so there is no comparison to draw.
18 of the studies in Dental Caries with a site in Egypt that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07786805Tanta UniversityBite Force Recovery Following Pediatric Full Crown Restorations | 2026-11 |
| NCT05943782Ain Shams UniversityEvaluation of CAD/CAM Onlays Fabricated by Subtractive Versus Additive Digital Manufacturing Techniques. | 2026-12-01 |
| NCT07612540Cairo UniversityRetention and Caries Prevention of Giomer Sealant With or Without Diode Laser Pre-treatment: A Randomized Controlled Trial | 2026-12-01 |
| NCT07262086Suez Canal UniversityClinical Evaluation of Wear Resistance and Bioactivity of Self Cured Bioactive Resin Composite | 2026-12-02 |
| NCT07711132Mansoura UniversityRemineralizing Effect of Nano-eggshell, Casein Phosphopeptide Amorphous Calcium Phosphate (CPP-ACP), and Sodium Fluoride on Initial Enamel Caries | 2026-12-20 |
Add all 18 to your calendar (.ics) → With an account.
Among the 207 studies in Dental Caries with a site in Egypt, from their registry updates:
This tab as a report to print or save as PDF → With an account.
: Assessment of Clinical, Radiographic, and Oral Health-Related Quality of Life Following Restoration of First Permanent Molars with Cention N: A 12-Month Split-Mouth Randomized Controlled Trial
Introduction
Dental caries is one of the most common chronic diseases affecting children. First permanent molars (FPMs) are particularly susceptible to caries because of their early eruption and complex occlusal anatomy. Restorative treatment aims to preserve tooth function and prevent disease progression. Composite resin is widely used because of its esthetics and mechanical properties; however, polymerization shrinkage may compromise marginal integrity. Cention N is a newer alkasite restorative material that releases fluoride, calcium, and hydroxide ions, promoting remineralization and enhancing caries resistance. Since treatment success should include both clinical outcomes and patient-centered outcomes, oral health-related quality of life (OHRQoL) will also be assessed.
Aim
To compare the clinical and radiographic performance of Cention N and bioactive injectable resin composite in restoring first permanent molars over 12 months. A secondary objective is to evaluate changes in children's oral health-related quality of life.
Materials and Methods
This will be a split-mouth randomized controlled clinical trial involving 100 children aged 8-10 years.
Inclusion criteria:
Healthy children (ASA I or II). Positive/definitely positive behavior (Frankl 3 or 4). Bilateral carious first permanent molars. Vital, asymptomatic teeth without radiographic pathology.
Exclusion criteria:
Lack of parental consent. ASA III or higher. Teeth with signs of irreversible pulp disease or radiographic pathology.
Ethical approval will be obtained from the Research Ethics Committee, Faculty of Dentistry, Minia University, and written informed consent will be obtained from parents.
Clinical Procedure
Following clinical and radiographic examination, local anesthesia and rubber dam isolation will be performed. Caries will be removed conservatively, followed by acid etching and adhesive application.
One molar will be restored with bioactive injectable resin composite according to the manufacturer's instructions.
The contralateral molar will be restored with Cention N, mixed and placed according to the manufacturer's instructions, with optional light curing.
All restorations will be finished and polished using standardized procedures.
Outcome Assessment
Primary outcome
Clinical and radiographic evaluation at 3, 6, and 12 months using the modified USPHS criteria, including:
Color match Marginal adaptation Marginal discoloration Anatomic form Secondary caries Restoration integrity
Secondary outcome Assessment of oral health-related quality of life using the Child Perceptions Questionnaire (CPQ8-10), which evaluates oral symptoms, functional limitations, emotional well-being, and social well-being.
Statistical Analysis
Collected data will be tabulated and analyzed using appropriate statistical methods to compare the performance of both restorative materials over the follow-up period.
Assessment of Clinical, Radiographic, and Oral Health-Related Quality of Life following restoration of First Permanent Molars with Cention-N: A 12-Month Split-Mouth Randomized Controlled Trial
Introduction
Dental caries is a prevalent chronic disease resulting from the interaction of acid-producing bacteria, fermentable carbohydrates, and host-related factors such as saliva and tooth morphology.
The first permanent molar (FPM) is recognized as one of the most caries-susceptible teeth in the mixed dentition. Its early eruption and the morphology of its occlusal surface make it highly prone to plaque retention and early carious involvement shortly after emergence.
Managing caries on the occlusal surfaces of permanent molars remains a clinical challenge, as these teeth consistently demonstrate the highest caries prevalence among permanent teeth.
Restorative treatment is required when carious lesions cause pain, functional impairment, or aesthetic concerns. Adhesive restorative materials provide durable sealing and bonding, which help arrest disease progression. Furthermore, achieving a smooth tooth-restoration interface is essential to support effective plaque control and reduce the risk of secondary caries.
A variety of tooth-colored restorative materials are available. The selection of an appropriate material should be guided by factors such as longevity and survival rate, esthetic qualities, physical characteristics, and overall biocompatibility.
Among tooth-colored restorative options, composite resins are widely used due to their esthetics, mechanical strength, and micromechanical bonding. However, polymerization shrinkage remains a limitation affecting marginal integrity.
More recently, Cention N has been introduced as an "alkaline" tooth-colored restorative material designed for bulk placement. It is a self-curing, UDMA-based material with optional light curing, incorporating alkaline glass fillers that release fluoride, calcium, and hydroxide ions, thereby supporting remineralization and enhancing caries resistance. With its radiopacity, high strength, and dense polymer network, Cention N presents a promising alternative to conventional composites.
Oral health-related quality of life (OHRQoL) reflects how oral conditions and their management influence daily functioning, well-being, and overall quality of life, providing a framework for a comprehensive evaluation of restorative outcome.
Given the advantages and limitations of both materials, the current research seeks to assess bioactive injectable composite (Shofu) and Cention N (Ivoclar Vivadent, Starter Kit) in restoring first permanent molars, thereby providing evidence-based guidance for material selection in children, as the success of restorative treatment extends beyond clinical outcomes to include the child's perception of oral health.
Aim of the study
The primary outcome of this study is the assessment of the clinical and radiographic performance of Cention N vs. resin composite in restorations of first permanent molars, while the secondary outcome is the evaluation of oral health-related quality of life (OHRQoL).
Materials and methods
This study is a 12-month split-mouth randomized controlled clinical trial designed to compare the clinical performance of Cention N and resin composite in restoring carious first permanent molars in children. The secondary objective is to evaluate the effect of both restorative materials on oral health-related quality of life (OHRQoL). The split-mouth design allows each participant to serve as their own control, thereby minimizing inter-individual variability.
Prior to treatment, the child and parent or guardian will receive an age-appropriate explanation of the clinical procedures, and behavior management techniques will be used to facilitate patient cooperation. A comprehensive clinical examination will be performed to determine the extent of the carious lesion and confirm the treatment plan.
When indicated, local anesthesia will be administered according to the child's body weight, medical history, and anticipated treatment duration. Before injection, the oral mucosa will be dried with sterile gauze, and 20% benzocaine topical anesthetic will be applied for 30-60 seconds to minimize discomfort. Inferior alveolar nerve block with long buccal nerve anesthesia will be used for mandibular molars, while local infiltration anesthesia will be administered for maxillary molars.
All restorative procedures will be performed under rubber dam isolation to ensure adequate moisture control. Before placement, patients will be screened for latex allergy, and a latex-free rubber dam will be used when required. A mouth prop will be used when necessary to improve patient comfort and access. Rubber dam isolation will be achieved using an appropriate molar clamp secured with dental floss as a safety ligature. A single hole will be punched for the treated tooth, the clamp will be positioned and checked for stability, and the rubber dam will be stretched over the clamp and secured to the frame. Interproximal contacts will be checked with dental floss to ensure proper isolation and patient comfort.
Cavity preparation will be carried out using standardized minimally invasive principles. Carious tissue will be removed using a high-speed diamond bur under continuous water coolant. The cavity walls will then be refined to obtain a sound cavity preparation suitable for adhesive restoration.
Following cavity preparation, enamel margins will be etched with 37% phosphoric acid for 30 seconds, thoroughly rinsed with an air-water spray for at least 30 seconds, and gently dried using oil-free compressed air. A dental adhesive system will then be applied according to the manufacturer's instructions and light-cured for 20 seconds before placement of the restorative material.
For teeth allocated to the resin composite group, Composite is applied directly out of the syringe into the cavity. It will be light-cured for 20 seconds to achieve adequate polymerization. Following placement, the restoration will be finished and polished to establish proper anatomical contour, marginal adaptation, and surface smoothness.
For teeth allocated to the Cention N group, the restorative material will be hand-mixed on a mixing pad using the manufacturer's recommended powder-to-liquid ratio of one scoop of powder to one drop of liquid (by volume). The material will be inserted into the prepared cavity, carefully adapted to the cavity walls, and condensed to optimize internal adaptation and marginal integrity. Optional light curing for 20 seconds will be performed according to the manufacturer's instructions to enhance polymerization and surface hardness. After complete setting, finishing and polishing procedures will be carried out to obtain appropriate anatomical form, occlusal harmony, and a smooth restoration surface.
All restorative procedures will be performed by the same trained operator using standardized clinical protocols to ensure consistency throughout the study. Participants will attend scheduled follow-up visits during the 12-month study period for assessment of restoration performance and evaluation of oral health-related quality of life using a validated questionnaire.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Clinical:
Radiographic:
Exclusion Criteria:
Clinical:
Radiographic:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
ASA physical status
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Following local anesthesia, rubber dam isolation, caries removal, and cavity preparation, enamel etching and adhesive application were performed, Cention N was hand-mixed according to the manufacturer's instructions (1 scoop powder:1 drop liquid), placed into the prepared cavity, adapted to the cavity walls, and condensed to ensure optimal marginal adaptation. Optional light curing for 20 seconds was performed, followed by finishing and polishing to obtain the final restoration.
Device: Cention-N
Following local anesthesia and rubber dam isolation, caries removal and cavity preparation were performed using a high-speed diamond bur under water cooling. Enamel margins were etched with 37% phosphoric acid for 30 seconds, rinsed, gently air-dried, and an adhesive system was applied and light-cured according to the manufacturer's instructions. The cavity was then restored with a bioactive injectable resin composite placed directly into the cavity and light-cured for 20 seconds. Finishing and polishing procedures were performed to achieve proper anatomical contour and smooth surface
Device: Resin Composite
Following local anesthesia, rubber dam isolation, caries removal, and cavity preparation, enamel etching and adhesive application were performed. Cention N was hand-mixed according to the manufacturer's instructions (1 scoop powder:1 drop liquid), placed into the prepared cavity, adapted to the cavity walls, and condensed to ensure optimal marginal adaptation. Optional light curing for 20 seconds was performed, followed by finishing and polishing to obtain the final restoration.
Following local anesthesia and rubber dam isolation, caries removal and cavity preparation were performed using a high-speed diamond bur under water cooling. Enamel margins were etched with 37% phosphoric acid for 30 seconds, rinsed, gently air-dried, and an adhesive system was applied and light-cured according to the manufacturer's instructions. The cavity was then restored with a bioactive injectable resin composite placed directly into the cavity and light-cured for 20 seconds. Finishing and polishing procedures were performed to achieve proper anatomical contour and smooth surface.
Color Match (CM)
Degree of shade harmony between restoration and natural tooth measured according to the modified United States Public Health Services (USPHS) criteria with scores (α, β, γ, and σ)
Time frame: "3,6,12 months"
Marginal Adaptation (MA)
Accuracy of the fit between restoration margins and tooth measured according the modified United States Public Health Services (USPHS) criteria with scores (α, β, γ, and σ)
Time frame: "3,6,12 months"
Marginal Discoloration (MD)
Presence of staining along the restoration-tooth interface measured according to the modified United States Public Health Services (USPHS) criteria with scores (α, β, γ, and σ)
Time frame: "3,6,12 months"
Anatomic Form (AF)
Ability of the restoration to reproduce natural tooth contour measured according to the modified United States Public Health Services (USPHS) criteria with scores (α, β, γ, and σ)
Time frame: "3,6,12 months"
Secondary Caries (SC)
Development of caries adjacent to the restoration measured according to the modified United States Public Health Services (USPHS) criteria with scores (α, β, γ, and σ)
Time frame: "3,6,12 months"
Restoration Integrity (RI)
Overall stability, wear resistance, and surface quality of the restoration measured according to the modified United States Public Health Services (USPHS) criteria with scores (α, β, γ, and σ)
Time frame: "3,6,12 months"
Oral Health Related Quality of Life
Child Perceptions Questionnaire (CPQ8-10), long form : The original English version of the Child Perceptions Questionnaire for children aged 8-10 years (CPQ8-10) consists of 25 items distributed across four domains: • Oral symptoms (5 items). • Functional limitations (5 items). • Emotional well-being (5 items) • Social well-being (10 items). The questionnaire begins with an introductory section and includes two general items recording the child's age and sex. The core section comprises 25 questions arranged in a standardized sequence, numbered consecutively from 1 to 25
Time frame: 1 year
Plan to share: No
Started Mar 2026 (actual). Primary completion is estimated for Mar 2027, 12 months after the start.
Of 470 non-industry interventional studies with no phase under Dental Caries, half reached primary completion within 15 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 30. This study's planned 12 months is below that.
Counting every sponsor, half of 503 studies reached it within 15 months; a quarter within 7 and three quarters within 29.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.